Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout

Clinical trial NCT01519687 · UNKNOWN

Trial details

NCT number: NCT01519687
Sponsor: Pharmos
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hyperuricemia Gout

Start date: 2012-01-01
Primary completion: 2012-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.